CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless

FRIDAY, Oct. 20, 2023 (HealthDay News) -- CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant doesn’t work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. An FDA advisory committee ruled last month that the ingredient was useless in easing congestion.
"We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores," the company told CBS MoneyWatch.
"Other oral cough and cold products will continue to be offered to meet consumer needs," the company added.
Another drugstore chain, Walgreens, said it "follows FDA [U.S. Food and Drug Administration] regulations,” but did not say if it would stop selling the medications.
“We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
More information
The National Library of Medicine has more on phenylephrine.
SOURCE: CBS News, Oct. 19, 2023
Related Posts
Pfizer Sends First Data to FDA on COVID-19 Vaccines for Younger Children
TUESDAY, Sept. 28, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that...
Fumar más vapear no es más saludable que solo fumar
VIERNES, 6 de mayo de 2022 (HealthDay News) -- Algunos fumadores usan los...
Nuevos opioides se están uniendo al suministro de drogas ilícitas y son más potentes que el fentanilo
MARTES, 5 de septiembre de 2023 (HealthDay News) -- En años recientes, la...
Subsequent Vaccination Cuts Risk for COVID-19 Reinfection
THURSDAY, March 3, 2022 (HealthDay News) -- For patients who have recovered from...